Safety and Immunogenicity of a Delayed Booster Dose of the Rvsvδg-Zebov-gp Vaccine for Prevention of Ebola Virus Disease: a Multicentre, Open-Label, Phase 2 Randomised Controlled Trial.Richard T. Davey Jr, Gary L. Collins,Nadine Rouphael,Guillaume Poliquin, Rosemary McConnell,Gabrielle Grubbs, Susan L. Moir,Joanne M. Langley,Marc Teitelbaum,Angela L. Hewlett,Susan L. F. McLellan,Nahid Bhadelia,Vanessa N. Raabe,Mark J. Mulligan, Irina Maljkovic Berry,Bonnie Dighero-Kemp,Jonathan R. Kurtz,Lisa E. Hensley, Nelson C. E. Dozier, Lindsay C. B. Marron, Alain DuChene,Jens H. Kuhn, Shawn K. Brown,Surender Khurana,H. Clifford Lane,James D. NeatonLANCET MICROBE（2024）引用 0|浏览2AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
